| 000 | 01634 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250512022031.0 | ||
| 264 | 0 | _c19880705 | |
| 008 | 198807s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/ana.410230304 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrost, J J | |
| 245 | 0 | 0 |
_aMu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cMar 1988 |
||
| 300 |
_a231-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 | _aCerebrovascular Circulation |
| 650 | 0 | 4 |
_aDeoxyglucose _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDominance, Cerebral _xphysiology |
| 650 | 0 | 4 |
_aEpilepsy, Temporal Lobe _xphysiopathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFentanyl _xanalogs & derivatives |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReceptors, Opioid _xphysiology |
| 650 | 0 | 4 | _aReceptors, Opioid, mu |
| 650 | 0 | 4 |
_aTemporal Lobe _xphysiopathology |
| 650 | 0 | 4 | _aTomography, Emission-Computed |
| 700 | 1 | _aMayberg, H S | |
| 700 | 1 | _aFisher, R S | |
| 700 | 1 | _aDouglass, K H | |
| 700 | 1 | _aDannals, R F | |
| 700 | 1 | _aLinks, J M | |
| 700 | 1 | _aWilson, A A | |
| 700 | 1 | _aRavert, H T | |
| 700 | 1 | _aRosenbaum, A E | |
| 700 | 1 | _aSnyder, S H | |
| 773 | 0 |
_tAnnals of neurology _gvol. 23 _gno. 3 _gp. 231-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ana.410230304 _zAvailable from publisher's website |
| 999 |
_c2842995 _d2842995 |
||